US129203A
(en)
*
|
|
1872-07-16 |
|
Improvement in animal-traps |
US175694A
(en)
*
|
|
1876-04-04 |
|
Improvement in sponge-cups |
US134351A
(en)
*
|
|
1872-12-31 |
|
Improvement in crutches |
US129584A
(en)
*
|
|
1872-07-16 |
|
Improvement in springs for gates and doors |
US3171820A
(en)
|
1964-02-17 |
1965-03-02 |
Scott Paper Co |
Reticulated polyurethane foams and process for their production
|
US3224404A
(en)
*
|
1964-11-06 |
1965-12-21 |
Jong George E De |
Mooring device
|
US4044126A
(en)
|
1972-04-20 |
1977-08-23 |
Allen & Hanburys Limited |
Steroidal aerosol compositions and process for the preparation thereof
|
GB1429184A
(en)
|
1972-04-20 |
1976-03-24 |
Allen & Hanburys Ltd |
Physically anti-inflammatory steroids for use in aerosols
|
US4302386A
(en)
*
|
1978-08-25 |
1981-11-24 |
The Ohio State University |
Antigenic modification of polypeptides
|
US4363877B1
(en)
*
|
1977-09-23 |
1998-05-26 |
Univ California |
Recombinant dna transfer vectors
|
US5221619A
(en)
*
|
1977-11-08 |
1993-06-22 |
Genentech, Inc. |
Method and means for microbial polypeptide expression
|
US4503035B1
(en)
|
1978-11-24 |
1996-03-19 |
Hoffmann La Roche |
Protein purification process and product
|
US4342832A
(en)
*
|
1979-07-05 |
1982-08-03 |
Genentech, Inc. |
Method of constructing a replicable cloning vehicle having quasi-synthetic genes
|
US4898830A
(en)
*
|
1979-07-05 |
1990-02-06 |
Genentech, Inc. |
Human growth hormone DNA
|
US5510472A
(en)
*
|
1979-11-21 |
1996-04-23 |
Yeda Research And Development Co. Ltd. |
Production of recombinant human interferon-beta2
|
US4816396A
(en)
*
|
1980-03-10 |
1989-03-28 |
Cetus Corporation |
Method and vector organism for controlled accumulation of heterologous gene products in bacillus subtilis
|
US6610830B1
(en)
|
1980-07-01 |
2003-08-26 |
Hoffman-La Roche Inc. |
Microbial production of mature human leukocyte interferons
|
US4462985A
(en)
|
1980-08-22 |
1984-07-31 |
University Of Illinois Foundation |
Delivery of biologically active components of heterologous species interferon isolates
|
US4678751A
(en)
|
1981-09-25 |
1987-07-07 |
Genentech, Inc. |
Hybrid human leukocyte interferons
|
US4775622A
(en)
*
|
1982-03-08 |
1988-10-04 |
Genentech, Inc. |
Expression, processing and secretion of heterologous protein by yeast
|
US4670393A
(en)
*
|
1982-03-22 |
1987-06-02 |
Genentech, Inc. |
DNA vectors encoding a novel human growth hormone-variant protein
|
US4446235A
(en)
*
|
1982-03-22 |
1984-05-01 |
Genentech, Inc. |
Method for cloning human growth hormone varient genes
|
US4665160A
(en)
*
|
1982-03-22 |
1987-05-12 |
Genentech, Inc. |
Novel human growth hormone like protein HGH-V encoded in the human genome
|
DE3220116A1
(de)
|
1982-05-28 |
1983-12-01 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
Mikrobiologisch hergestellte (alpha)- und ss-interferone, dna-sequenzen, die fuer diese interferone codieren, mikroorganismen, die diese genetische information enthalten, und verfahren zu ihrer herstellung
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
US4588585A
(en)
*
|
1982-10-19 |
1986-05-13 |
Cetus Corporation |
Human recombinant cysteine depleted interferon-β muteins
|
US5618697A
(en)
*
|
1982-12-10 |
1997-04-08 |
Novo Nordisk A/S |
Process for preparing a desired protein
|
US4497795A
(en)
|
1982-12-13 |
1985-02-05 |
The Texas A&M University System |
Method of regulating appetite and efficiency of food utilization employing interferon
|
US4820515A
(en)
|
1982-12-13 |
1989-04-11 |
Texas A&M University System |
Method of using interferon in low dosage to regulate appetite and efficiency of food utilization
|
US5910304A
(en)
|
1982-12-13 |
1999-06-08 |
Texas A&M University System |
Low-dose oral administration of interferons
|
US4518584A
(en)
*
|
1983-04-15 |
1985-05-21 |
Cetus Corporation |
Human recombinant interleukin-2 muteins
|
US4859600A
(en)
*
|
1983-04-25 |
1989-08-22 |
Genentech, Inc. |
Recombinant procaryotic cell containing correctly processed human growth hormone
|
US4755465A
(en)
*
|
1983-04-25 |
1988-07-05 |
Genentech, Inc. |
Secretion of correctly processed human growth hormone in E. coli and Pseudomonas
|
GB8317880D0
(en)
*
|
1983-07-01 |
1983-08-03 |
Searle & Co |
Structure and synthesis of interferons
|
US5670371A
(en)
*
|
1983-07-15 |
1997-09-23 |
Bio-Technology General Corp. |
Bacterial expression of superoxide dismutase
|
BG49718A3
(en)
*
|
1983-07-15 |
1992-01-15 |
Bio Technology General Corp |
Method for preparing of polypeptid with superoxiddismutasne activitty
|
US5637495A
(en)
*
|
1983-07-15 |
1997-06-10 |
Bio-Technology General Corp. |
Plasmids for production of human growth hormone or polypeptide analog thereof, hosts containing the plasmids, products manufactured thereby, and related methods
|
US5256546A
(en)
*
|
1983-07-15 |
1993-10-26 |
Bio-Technology General Corp. |
Bacterial expression of porcine growth hormone
|
US5198361A
(en)
*
|
1983-07-15 |
1993-03-30 |
Bio-Technology General Corp. |
Plasmids for production of met-asp-gln bovine growth hormone, hosts containing the plasmids, products manufactured thereby and related methods
|
NZ210501A
(en)
*
|
1983-12-13 |
1991-08-27 |
Kirin Amgen Inc |
Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
|
KR850004274A
(ko)
*
|
1983-12-13 |
1985-07-11 |
원본미기재 |
에리트로포이에틴의 제조방법
|
US4703008A
(en)
*
|
1983-12-13 |
1987-10-27 |
Kiren-Amgen, Inc. |
DNA sequences encoding erythropoietin
|
GB8412564D0
(en)
*
|
1984-05-17 |
1984-06-20 |
Searle & Co |
Structure and properties
|
US4747825A
(en)
*
|
1984-06-29 |
1988-05-31 |
Ferring Laboratories, Inc. |
Apparatus and methodology for pulsed administration of growth promoting agents
|
US4937076A
(en)
*
|
1984-08-10 |
1990-06-26 |
Combe Incorporated |
Chewable aspirin and buffering material tablet and method for producing same
|
US4797368A
(en)
|
1985-03-15 |
1989-01-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adeno-associated virus as eukaryotic expression vector
|
CH0229046H1
(de)
|
1985-03-30 |
1998-07-15 |
Stuart Alan Kauffman |
Method for obtaining dna, rna, peptides, polypeptinique. des or proteins by means of a dna recombinant tech
|
US5198345A
(en)
|
1985-04-15 |
1993-03-30 |
Gist-Brocades N.V. |
Vectors in use in filamentous fungi
|
US4845196A
(en)
*
|
1985-06-24 |
1989-07-04 |
G. D. Searle & Co. |
Modified interferon gammas
|
US5391485A
(en)
*
|
1985-08-06 |
1995-02-21 |
Immunex Corporation |
DNAs encoding analog GM-CSF molecules displaying resistance to proteases which cleave at adjacent dibasic residues
|
US4810643A
(en)
*
|
1985-08-23 |
1989-03-07 |
Kirin- Amgen Inc. |
Production of pluripotent granulocyte colony-stimulating factor
|
US5631227A
(en)
*
|
1985-09-18 |
1997-05-20 |
The Upjohn Company |
Somatotropin analogs
|
US5139941A
(en)
|
1985-10-31 |
1992-08-18 |
University Of Florida Research Foundation, Inc. |
AAV transduction vectors
|
IL77186A0
(en)
*
|
1985-11-29 |
1986-04-29 |
Touitou Elka |
Pharmaceutical insulin composition
|
US5298603A
(en)
*
|
1985-12-21 |
1994-03-29 |
Hoechst Aktiengesellschaft |
GM-CSF protein, its derivatives, the preparation of proteins of this type, and their use
|
US4820514A
(en)
|
1985-12-30 |
1989-04-11 |
Texas A&M University System |
Low dosage of interferon to enhance vaccine efficiency
|
US6548640B1
(en)
|
1986-03-27 |
2003-04-15 |
Btg International Limited |
Altered antibodies
|
EP0240224A3
(de)
*
|
1986-03-31 |
1989-02-01 |
Interferon Sciences, Inc. |
Alpha-Interferon-Analogon
|
US4959217A
(en)
*
|
1986-05-22 |
1990-09-25 |
Syntex (U.S.A.) Inc. |
Delayed/sustained release of macromolecules
|
DK173067B1
(da)
*
|
1986-06-27 |
1999-12-13 |
Univ Washington |
Humant erythropoietin-gen, fremgangsmåde til ekspression deraf i transficerede cellelinier, de transficerede cellelinier sa
|
DE3683910D1
(de)
|
1986-09-05 |
1992-03-26 |
Cetus Corp |
Oxidationsresistente muteine von beta-interferon, deren herstellung und diese muteine enthaltende praeparate.
|
US5183746A
(en)
*
|
1986-10-27 |
1993-02-02 |
Schering Aktiengesellschaft |
Formulation processes for pharmaceutical compositions of recombinant β-
|
ZA878295B
(en)
|
1986-11-06 |
1988-05-03 |
Amarillo Cell Culture Co. Inc. |
Treatment of immuno-resistant disease
|
CA1320905C
(en)
|
1986-11-06 |
1993-08-03 |
Joseph M. Cummins |
Treatment of immuno-resistant disease
|
US5013718A
(en)
*
|
1986-11-21 |
1991-05-07 |
Amgen, Inc. |
Method for treating iron overload using EPO
|
US5214132A
(en)
*
|
1986-12-23 |
1993-05-25 |
Kyowa Hakko Kogyo Co., Ltd. |
Polypeptide derivatives of human granulocyte colony stimulating factor
|
US4835260A
(en)
*
|
1987-03-20 |
1989-05-30 |
Genetics Institute, Inc. |
Erythropoietin composition
|
US4904584A
(en)
*
|
1987-12-23 |
1990-02-27 |
Genetics Institute, Inc. |
Site-specific homogeneous modification of polypeptides
|
US5017371A
(en)
|
1988-01-06 |
1991-05-21 |
Amarillo Cell Culture Company, Incorporated |
Method for reducing side effects of cancer therapy
|
US5698418A
(en)
*
|
1988-02-17 |
1997-12-16 |
Pharmacia & Upjohn Company |
Fermentation media and methods for controlling norleucine in polypeptides
|
US5068317A
(en)
*
|
1988-03-15 |
1991-11-26 |
Eli Lilly And Company |
Novel derivative of human growth hormone
|
US5445826A
(en)
*
|
1988-06-28 |
1995-08-29 |
Cibus Pharmaceutical, Inc. |
Delivery system containing a gel-forming dietary fiber and a drug
|
CA1333777C
(en)
*
|
1988-07-01 |
1995-01-03 |
Randy M. Berka |
Aspartic proteinase deficient filamentous fungi
|
US5079345A
(en)
*
|
1988-08-19 |
1992-01-07 |
Eli Lilly And Company |
Proteins having growth hormone anabolic properties with reduced effect on carbohydrate metabolism
|
ATE198353T1
(de)
*
|
1988-08-24 |
2001-01-15 |
American Cyanamid Co |
Stabilisierung von somatotropinen durch modifikation von cystein-resten durch orts- spezifische mutagenese oder chemische derivatisierung
|
US5130422A
(en)
*
|
1988-08-29 |
1992-07-14 |
Monsanto Company |
Variant somatotropin-encoding DNA
|
US5089473A
(en)
*
|
1988-08-29 |
1992-02-18 |
Monsanto Company |
Somatotropin variants and their use
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
US5079230A
(en)
*
|
1988-09-12 |
1992-01-07 |
Pitman-Moore, Inc. |
Stable bioactive somatotropins
|
GB8824591D0
(en)
*
|
1988-10-20 |
1988-11-23 |
Royal Free Hosp School Med |
Fractionation process
|
CA2001774C
(en)
*
|
1988-10-28 |
2001-10-16 |
James A. Wells |
Method for identifying active domains and amino acid residues in polypeptides and hormone variants
|
US5534617A
(en)
*
|
1988-10-28 |
1996-07-09 |
Genentech, Inc. |
Human growth hormone variants having greater affinity for human growth hormone receptor at site 1
|
US5688666A
(en)
*
|
1988-10-28 |
1997-11-18 |
Genentech, Inc. |
Growth hormone variants with altered binding properties
|
US6780613B1
(en)
*
|
1988-10-28 |
2004-08-24 |
Genentech, Inc. |
Growth hormone variants
|
US5096815A
(en)
|
1989-01-06 |
1992-03-17 |
Protein Engineering Corporation |
Generation and selection of novel dna-binding proteins and polypeptides
|
US5101018A
(en)
*
|
1989-06-12 |
1992-03-31 |
International Minerals & Chemical Corp. |
Method for recovering recombinant proteins
|
US5663305A
(en)
*
|
1989-07-10 |
1997-09-02 |
The Upjohn Company |
Somatotropin analogs
|
DE3923963A1
(de)
*
|
1989-07-20 |
1991-01-31 |
Behringwerke Ag |
Muteine des menschlichen erythropoetins, ihre herstellung und ihre verwendung
|
US5047511A
(en)
*
|
1989-08-28 |
1991-09-10 |
Pitman-Moore, Inc. |
Method for recovering recombinant proteins
|
US5436146A
(en)
|
1989-09-07 |
1995-07-25 |
The Trustees Of Princeton University |
Helper-free stocks of recombinant adeno-associated virus vectors
|
US6583115B1
(en)
*
|
1989-10-12 |
2003-06-24 |
Ohio University/Edison Biotechnology Institute |
Methods for treating acromegaly and giantism with growth hormone antagonists
|
US5958879A
(en)
*
|
1989-10-12 |
1999-09-28 |
Ohio University/Edison Biotechnology Institute |
Growth hormone receptor antagonists and methods of reducing growth hormone activity in a mammal
|
US5350836A
(en)
*
|
1989-10-12 |
1994-09-27 |
Ohio University |
Growth hormone antagonists
|
US6787336B1
(en)
*
|
1989-10-12 |
2004-09-07 |
Ohio University/Edison Biotechnology Institute |
DNA encoding growth hormone antagonists
|
US5856298A
(en)
*
|
1989-10-13 |
1999-01-05 |
Amgen Inc. |
Erythropoietin isoforms
|
JPH03151399A
(ja)
|
1989-11-07 |
1991-06-27 |
Snow Brand Milk Prod Co Ltd |
変異ヒトエリスロポエチン
|
CA2072587A1
(en)
*
|
1990-01-08 |
1991-07-09 |
Gail F. Seelig |
Oxidized variants of gm-csf
|
US5109121A
(en)
*
|
1990-01-22 |
1992-04-28 |
Pitman-Moore, Inc. |
Method for recovering recombinant proteins
|
US4988798A
(en)
*
|
1990-01-22 |
1991-01-29 |
Pitman-Moore, Inc. |
Method for recovering recombinant proteins
|
US5262568A
(en)
|
1990-03-02 |
1993-11-16 |
State Of Oregon |
Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
|
EP0527809B1
(de)
|
1990-04-05 |
1995-08-16 |
CREA, Roberto |
"walk-through"-mutagenese
|
GB9107846D0
(en)
*
|
1990-04-30 |
1991-05-29 |
Ici Plc |
Polypeptides
|
US5951972A
(en)
*
|
1990-05-04 |
1999-09-14 |
American Cyanamid Company |
Stabilization of somatotropins and other proteins by modification of cysteine residues
|
US5399345A
(en)
*
|
1990-05-08 |
1995-03-21 |
Boehringer Mannheim, Gmbh |
Muteins of the granulocyte colony stimulating factor
|
PL166045B1
(pl)
|
1990-06-04 |
1995-03-31 |
Schering Corp |
Sposób wytwarzania krystalicznego I nterferonu alfa-2 PL PL PL PL
|
US5849694A
(en)
*
|
1990-07-16 |
1998-12-15 |
Synenki; Richard M. |
Stable and bioactive modified porcine somatotropin and pharmaceutical compositions thereof
|
IE912365A1
(en)
*
|
1990-07-23 |
1992-01-29 |
Zeneca Ltd |
Continuous release pharmaceutical compositions
|
US5871974A
(en)
|
1990-09-28 |
1999-02-16 |
Ixsys Inc. |
Surface expression libraries of heteromeric receptors
|
US6258530B1
(en)
|
1990-09-28 |
2001-07-10 |
Ixsys, Inc. |
Surface expression libraries of randomized peptides
|
US5770434A
(en)
|
1990-09-28 |
1998-06-23 |
Ixsys Incorporated |
Soluble peptides having constrained, secondary conformation in solution and method of making same
|
US5215741A
(en)
|
1990-10-30 |
1993-06-01 |
Amarillo Cell Culture Company, Incorporated |
Method for prevention of parasite infections
|
CA2044468C
(en)
*
|
1990-11-21 |
2006-08-22 |
Richard A. Nash |
Canine granulocyte macrophage colony stimulating factor
|
NZ260103A
(en)
*
|
1990-11-30 |
1996-10-28 |
Bio Technology General Corp |
Somatotropin with alterations in the alpha-helix-1 region
|
US5310882A
(en)
*
|
1990-11-30 |
1994-05-10 |
American Cyanamid Company |
Somatotropins with alterations in the α-helix 3 region
|
CA2095633C
(en)
*
|
1990-12-03 |
2003-02-04 |
Lisa J. Garrard |
Enrichment method for variant proteins with altered binding properties
|
ES2087323T3
(es)
*
|
1991-02-19 |
1996-07-16 |
Takeda Chemical Industries Ltd |
Metodo para producir peptidos exentos de cisteina.
|
ATE196548T1
(de)
*
|
1991-05-10 |
2000-10-15 |
Genentech Inc |
Auswählen von agonisten und antagonisten von liganden
|
NZ245015A
(en)
*
|
1991-11-05 |
1995-12-21 |
Transkaryotic Therapies Inc |
Delivery of human growth hormone through the administration of transfected cell lines encoding human growth hormone, which are physically protected from host immune response; the transfected cells and their production
|
US5733761A
(en)
*
|
1991-11-05 |
1998-03-31 |
Transkaryotic Therapies, Inc. |
Protein production and protein delivery
|
US5676942A
(en)
*
|
1992-02-10 |
1997-10-14 |
Interferon Sciences, Inc. |
Composition containing human alpha interferon species proteins and method for use thereof
|
JPH05289267A
(ja)
*
|
1992-04-07 |
1993-11-05 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラー写真感光材料
|
US5614184A
(en)
*
|
1992-07-28 |
1997-03-25 |
New England Deaconess Hospital |
Recombinant human erythropoietin mutants and therapeutic methods employing them
|
US6153407A
(en)
*
|
1992-07-28 |
2000-11-28 |
Beth Israel Deaconess Medical Center |
Erythropoietin DNA having modified 5' and 3' sequences and its use to prepare EPO therapeutics
|
US6436387B1
(en)
*
|
1992-11-24 |
2002-08-20 |
G.D. Searle & Co. |
Methods of ex-vivo expansion of hematopoietic cells using multivariant IL-3 hematopoiesis chimera proteins
|
US5581476A
(en)
*
|
1993-01-28 |
1996-12-03 |
Amgen Inc. |
Computer-based methods and articles of manufacture for preparing G-CSF analogs
|
US5441734A
(en)
|
1993-02-25 |
1995-08-15 |
Schering Corporation |
Metal-interferon-alpha crystals
|
JPH08509614A
(ja)
*
|
1993-04-29 |
1996-10-15 |
アボツト・ラボラトリーズ |
エリスロポエチン類似体組成物および方法
|
EP0626448A3
(de)
|
1993-05-26 |
1998-01-14 |
BOEHRINGER INGELHEIM INTERNATIONAL GmbH |
Verfahren zur Herstellung und Reinigung von alpha-Interferon
|
WO1994029344A1
(en)
|
1993-06-11 |
1994-12-22 |
Pestka Biomedical Laboratories, Inc. |
Super proteins including interferons and interleukins
|
US6299870B1
(en)
|
1993-06-11 |
2001-10-09 |
Pbl Biomedical Laboratories |
Mutant human interferons
|
WO1995004075A1
(en)
*
|
1993-07-28 |
1995-02-09 |
Medvet Science Pty. Ltd. |
Haemopoietic growth factor antagonists
|
US5424289A
(en)
*
|
1993-07-30 |
1995-06-13 |
Alza Corporation |
Solid formulations of therapeutic proteins for gastrointestinal delivery
|
US5798500A
(en)
*
|
1993-08-10 |
1998-08-25 |
Stillwagon, Jr.; Ross I. |
Curling iron stove with internal cavity with electric heater positioned therebelow
|
CN1057534C
(zh)
|
1993-08-17 |
2000-10-18 |
柯瑞英-艾格公司 |
促红细胞生成素类似物
|
US5976552A
(en)
*
|
1995-04-28 |
1999-11-02 |
Protein Sciences Corporation |
Virus vaccines
|
AU1282895A
(en)
*
|
1993-12-29 |
1995-07-17 |
Sumitomo Pharmaceuticals Company, Limited |
Novel human ciliary neurotrophic factor
|
US5597709A
(en)
*
|
1994-01-27 |
1997-01-28 |
Human Genome Sciences, Inc. |
Human growth hormone splice variants hGHV-2(88) and hGHV-3(53)
|
US6335160B1
(en)
|
1995-02-17 |
2002-01-01 |
Maxygen, Inc. |
Methods and compositions for polypeptide engineering
|
US6165793A
(en)
|
1996-03-25 |
2000-12-26 |
Maxygen, Inc. |
Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
|
US5605793A
(en)
|
1994-02-17 |
1997-02-25 |
Affymax Technologies N.V. |
Methods for in vitro recombination
|
US6117679A
(en)
|
1994-02-17 |
2000-09-12 |
Maxygen, Inc. |
Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
|
US6245900B1
(en)
*
|
1994-02-23 |
2001-06-12 |
Kyowa Hakko Kogyo Co., Ltd. |
Platelet production promoting agent
|
EP0748338A4
(de)
|
1994-03-04 |
2001-03-28 |
Merck & Co Inc |
In vitro reifung von antikörpern mittels alanin 'scanning' mutagenese
|
US5545723A
(en)
*
|
1994-03-15 |
1996-08-13 |
Biogen Inc. |
Muteins of IFN-β
|
US5580853A
(en)
*
|
1994-03-22 |
1996-12-03 |
New England Deaconess Hospital |
Modified polypeptides with increased biological activity
|
US5747446A
(en)
*
|
1994-03-22 |
1998-05-05 |
Beth Israel Deaconess Medical Center |
Modified polypeptides with increased biological activity
|
US6024734A
(en)
|
1994-03-31 |
2000-02-15 |
Brewitt; Barbara A. |
Treatment methods using homeopathic preparations of growth factors
|
US5635599A
(en)
*
|
1994-04-08 |
1997-06-03 |
The United States Of America As Represented By The Department Of Health And Human Services |
Fusion proteins comprising circularly permuted ligands
|
US6346243B1
(en)
|
1994-04-12 |
2002-02-12 |
Research Development Foundation |
Inhibition of transplant rejection by type one interferon
|
JP3560639B2
(ja)
|
1994-05-26 |
2004-09-02 |
株式会社タカハシキカン |
焼却炉
|
FR2722208B1
(fr)
|
1994-07-05 |
1996-10-04 |
Inst Nat Sante Rech Med |
Nouveau site interne d'entree des ribosomes, vecteur le contenant et utilisation therapeutique
|
US5460232A
(en)
*
|
1994-07-25 |
1995-10-24 |
Central Mine Equipment Company |
Rotary earth drill bit socket shield
|
US6099830A
(en)
*
|
1994-08-09 |
2000-08-08 |
Zymogenetics, Inc. |
Methods for stimulating erythropoiesis using hematopoietic proteins
|
IL116085A
(en)
*
|
1994-12-16 |
1999-12-31 |
Ortho Pharma Corp |
Spray dried erythropoietin
|
IL116816A
(en)
|
1995-01-20 |
2003-05-29 |
Rhone Poulenc Rorer Sa |
Cell for the production of a defective recombinant adenovirus or an adeno-associated virus and the various uses thereof
|
US6387365B1
(en)
|
1995-05-19 |
2002-05-14 |
Schering Corporation |
Combination therapy for chronic hepatitis C infection
|
US5871723A
(en)
|
1995-06-06 |
1999-02-16 |
The Regent Of The University Of Michigan |
CXC chemokines as regulators of angiogenesis
|
US5814485A
(en)
*
|
1995-06-06 |
1998-09-29 |
Chiron Corporation |
Production of interferon-β (IFN-β) in E. coli
|
US5854049A
(en)
*
|
1995-06-09 |
1998-12-29 |
President And Fellows Of Harvard College |
Plasmin-resistant streptokinase
|
AUPN378095A0
(en)
*
|
1995-06-23 |
1995-07-20 |
Bresagen Limited |
Haemopoietic growth factor antagonists and uses therefor
|
NZ286884A
(en)
*
|
1995-06-29 |
1997-12-19 |
Mitsui Chemicals Inc |
Use of 20 kd human growth hormone in hrt, increasing serum igf-1 levels and stimulating lipolysis
|
US6057103A
(en)
|
1995-07-18 |
2000-05-02 |
Diversa Corporation |
Screening for novel bioactivities
|
DE19535853C2
(de)
*
|
1995-09-18 |
1999-04-01 |
Fraunhofer Ges Forschung |
Varianten des rekombinanten humanen Interferon-gamma, Verfahren zu ihrer Herstellung und ihre Verwendung
|
ES2338431T3
(es)
*
|
1995-09-21 |
2010-05-07 |
Genentech, Inc. |
Variantes de la hormona de crecimiento humano.
|
CA2329474C
(en)
|
1995-11-02 |
2002-02-26 |
Schering Corporation |
Continuous low-dose cytokine infusion therapy
|
US6479258B1
(en)
|
1995-12-07 |
2002-11-12 |
Diversa Corporation |
Non-stochastic generation of genetic vaccines
|
US20030215798A1
(en)
|
1997-06-16 |
2003-11-20 |
Diversa Corporation |
High throughput fluorescence-based screening for novel enzymes
|
US6238884B1
(en)
|
1995-12-07 |
2001-05-29 |
Diversa Corporation |
End selection in directed evolution
|
US6171820B1
(en)
|
1995-12-07 |
2001-01-09 |
Diversa Corporation |
Saturation mutagenesis in directed evolution
|
EP0876512A1
(de)
|
1996-01-23 |
1998-11-11 |
Viropharma Incorporated |
Verfahren zur Identifizierung von RNA-Virus spezifischen Hemmstoffen
|
EP0790305B1
(de)
*
|
1996-02-13 |
2002-04-24 |
JCR PHARMACEUTICALS Co., LTD. |
Hormones de croissance humaines mutantes et leur utilisation
|
DE69706657T2
(de)
|
1996-02-28 |
2002-06-20 |
Unihart Corp |
Natürliches menschliches alpha interferon enthaltende pharmazeutische zusammensetzungen
|
US6096548A
(en)
|
1996-03-25 |
2000-08-01 |
Maxygen, Inc. |
Method for directing evolution of a virus
|
AU2595697A
(en)
*
|
1996-03-29 |
1997-10-22 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US6204022B1
(en)
|
1996-04-12 |
2001-03-20 |
Pepgen Corporation And University Of Florida |
Low-toxicity human interferon-alpha analogs
|
US6207145B1
(en)
|
1997-05-09 |
2001-03-27 |
Pharma Pacific Pty Ltd. |
Therapeutic applications of high dose interferon
|
CA2253971A1
(en)
|
1996-05-09 |
1997-11-13 |
Pharma Pacific Pty.Ltd. |
Use of high dose interferon by oralmucosal contact to treat viral infections and neoplastic conditions
|
CN1151840C
(zh)
|
1996-05-09 |
2004-06-02 |
太平洋制药控股公司 |
干扰素在制备用于治疗哺乳动物肿瘤病的药剂中的应用
|
US5763239A
(en)
|
1996-06-18 |
1998-06-09 |
Diversa Corporation |
Production and use of normalized DNA libraries
|
WO1998007878A2
(en)
*
|
1996-08-23 |
1998-02-26 |
Arch Development Corporation |
Long-term expression of gene products by transforming muscle cells
|
WO1998013487A1
(en)
|
1996-09-27 |
1998-04-02 |
Maxygen, Inc. |
Methods for optimization of gene therapy by recursive sequence shuffling and selection
|
US6967092B1
(en)
*
|
1996-10-25 |
2005-11-22 |
Mc Kearn John P |
Multi-functional chimeric hematopoietic receptor agonists
|
DE19648625A1
(de)
*
|
1996-11-13 |
1998-05-14 |
Soft Gene Gmbh |
Mikroprojektil für das Einbringen von Substanzen in Zellen durch ballistischen Transfer
|
US5862514A
(en)
|
1996-12-06 |
1999-01-19 |
Ixsys, Inc. |
Method and means for synthesis-based simulation of chemicals having biological functions
|
BR9606270A
(pt)
*
|
1996-12-18 |
1998-09-22 |
Univ Minas Gerais |
Processo para a produção da proteína do interferon beta-cis humano recombinante e proteína de interferon beta-cis humano recombinante
|
US6884419B1
(en)
*
|
1996-12-23 |
2005-04-26 |
Kyowa Hakko Kogyo, Co., Ltd. |
hG-CSF fusion polypeptide having c-mpl activity, DNA coding for same and methods of treating anemia using same
|
US5779434A
(en)
|
1997-02-06 |
1998-07-14 |
Baker Hughes Incorporated |
Pump mounted thrust bearing
|
DE19717864C2
(de)
*
|
1997-04-23 |
2001-05-17 |
Fraunhofer Ges Forschung |
Humanes rekombinantes Interferon-beta, Verfahren zu seiner Herstellung und seine Verwendung
|
US6153420A
(en)
*
|
1997-04-24 |
2000-11-28 |
Zymogenetics, Inc. |
Serine protease polypeptides and materials and methods for making them
|
AU729630B2
(en)
*
|
1997-05-08 |
2001-02-08 |
Chugai Seiyaku Kabushiki Kaisha |
Prophylactic/therapeutic agents for atherosclerosis
|
AU7383298A
(en)
*
|
1997-05-13 |
1998-12-08 |
Regents Of The University Of California, The |
Novel antiangiogenic peptide agents and their therapeutic and diagnostic use
|
US6165476A
(en)
*
|
1997-07-10 |
2000-12-26 |
Beth Israel Deaconess Medical Center |
Fusion proteins with an immunoglobulin hinge region linker
|
US6753165B1
(en)
*
|
1999-01-14 |
2004-06-22 |
Bolder Biotechnology, Inc. |
Methods for making proteins containing free cysteine residues
|
IL133974A0
(en)
*
|
1997-07-14 |
2001-04-30 |
Bolder Biotechnology Inc |
Derivatives of growth hormone and related proteins
|
US7153943B2
(en)
*
|
1997-07-14 |
2006-12-26 |
Bolder Biotechnology, Inc. |
Derivatives of growth hormone and related proteins, and methods of use thereof
|
US7270809B2
(en)
|
1997-07-14 |
2007-09-18 |
Bolder Biotechnology, Inc. |
Cysteine variants of alpha interferon-2
|
NZ502993A
(en)
*
|
1997-09-08 |
2002-12-20 |
Metabolic Pharm Ltd |
Treatment of obesity using hGH 177-191analogues
|
US6156509A
(en)
|
1997-11-12 |
2000-12-05 |
Genencor International, Inc. |
Method of increasing efficiency of directed evolution of a gene using phagemid
|
US6897297B1
(en)
|
1997-12-03 |
2005-05-24 |
Curis, Inc. |
Hydrophobically-modified protein compositions and methods
|
US6165458A
(en)
|
1997-12-26 |
2000-12-26 |
Pharmaderm Laboratories Ltd. |
Composition and method for dermal and transdermal administration of a cytokine
|
US6274158B1
(en)
*
|
1998-02-04 |
2001-08-14 |
Veronica L. Zaharia Czeizler |
Treatment with recombinant human erythropoietin of bleeding in patients with normal and abnormal hemostasis
|
SI0937456T1
(en)
*
|
1998-02-23 |
2004-12-31 |
Cilag Ag International |
Erythropoietin liposomal dispersion
|
US6036949A
(en)
|
1998-03-05 |
2000-03-14 |
Amarillo Biosciences, Inc. |
Treatment of fibromyalgia with low doses of interferon
|
US6676937B1
(en)
*
|
1998-03-09 |
2004-01-13 |
Caritas St. Elizabeth's Medical Center Of Boston Inc. |
Compositions and methods for modulating vascularization
|
US20040228834A1
(en)
*
|
1998-03-09 |
2004-11-18 |
Jeffrey Isner |
Compositions and methods for modulating vascularization
|
US6174406B1
(en)
*
|
1998-04-09 |
2001-01-16 |
International Business Machines Corporation |
Bonding together surfaces
|
US6413776B1
(en)
|
1998-06-12 |
2002-07-02 |
Galapagos Geonomics N.V. |
High throughput screening of gene function using adenoviral libraries for functional genomics applications
|
AU775422B2
(en)
*
|
1998-06-15 |
2004-07-29 |
Gtc Biotherapeutics, Inc. |
Erythropoietin analog-human serum albumin fusion
|
US6472512B1
(en)
*
|
1998-07-21 |
2002-10-29 |
Human Genome Sciences, Inc. |
Keratinocyte derived interferon
|
PT1121382E
(pt)
*
|
1998-10-16 |
2006-10-31 |
Biogen Idec Inc |
Proteinas de fusao do interferao beta e as respectivas utilizacoes
|
PT1121156E
(pt)
*
|
1998-10-16 |
2006-05-31 |
Biogen Idec Inc |
Conjugados de polimeros de interferao-beta-1a e as suas utilizacoes
|
AUPP660698A0
(en)
|
1998-10-21 |
1998-11-12 |
University Of Queensland, The |
A method of protein engineering
|
EP1147011A1
(de)
|
1998-11-25 |
2001-10-24 |
Amarillo Biosciences, Inc. |
Durch alpha-interferon vermittelte steigerung der aquaporin expression
|
AU2346900A
(en)
*
|
1998-11-30 |
2000-06-19 |
Eli Lilly And Company |
Erythropoietic compounds
|
US6171620B1
(en)
*
|
1999-04-27 |
2001-01-09 |
Health Research, Inc. |
Method of enhancing the efficacy of anti-tumor agents
|
US6831060B2
(en)
*
|
1999-05-07 |
2004-12-14 |
Genentech, Inc. |
Chimpanzee erythropoietin (CHEPO) polypeptides and nucleic acids encoding the same
|
US6555343B1
(en)
*
|
1999-05-07 |
2003-04-29 |
Genentech Inc. |
Chimpanzee erythropoietin (CHEPO) polypeptides and nucleic acids encoding the same
|
US6946265B1
(en)
*
|
1999-05-12 |
2005-09-20 |
Xencor, Inc. |
Nucleic acids and proteins with growth hormone activity
|
US6514729B1
(en)
*
|
1999-05-12 |
2003-02-04 |
Xencor, Inc. |
Recombinant interferon-beta muteins
|
US6710025B1
(en)
*
|
1999-05-26 |
2004-03-23 |
The Brigham And Women's Hospital, Inc. |
Treatment of damaged tissue using agents that modulate the activity of alpha-smooth muscle actin
|
US6319691B1
(en)
*
|
1999-06-15 |
2001-11-20 |
Usa Universe Bioengineering, Inc. |
Fusion proteins comprising IFN-alpha2b and TM-alpha1
|
US6566329B1
(en)
*
|
1999-06-28 |
2003-05-20 |
Novo Nordisk A/S |
Freeze-dried preparation of human growth hormone
|
CZ299516B6
(cs)
*
|
1999-07-02 |
2008-08-20 |
F. Hoffmann-La Roche Ag |
Konjugát erythropoetinového glykoproteinu, zpusobjeho výroby a použití a farmaceutická kompozice sjeho obsahem
|
KR100356140B1
(ko)
*
|
1999-07-08 |
2002-10-19 |
한미약품공업 주식회사 |
인간 과립구 콜로니 자극인자 변이체 및 이의 생산 방법
|
US7144574B2
(en)
*
|
1999-08-27 |
2006-12-05 |
Maxygen Aps |
Interferon β variants and conjugates
|
US6531122B1
(en)
*
|
1999-08-27 |
2003-03-11 |
Maxygen Aps |
Interferon-β variants and conjugates
|
JP2003510295A
(ja)
|
1999-09-28 |
2003-03-18 |
アマリロ バイオサイエンシズ,インコーポレイテッド |
疾患の治療のための低投与量のifnガンマ
|
US20040002474A1
(en)
|
1999-10-07 |
2004-01-01 |
Maxygen Inc. |
IFN-alpha homologues
|
AU8001300A
(en)
*
|
1999-10-07 |
2001-05-10 |
Maxygen, Inc. |
Ifn-alpha homologues
|
WO2001032711A2
(en)
|
1999-10-21 |
2001-05-10 |
Board Of Trustees Of The University Of Arkansas |
Adeno-associated virus aav rep78 major regulatory protein, mutants thereof and uses thereof
|
CA2388982A1
(en)
|
1999-11-05 |
2001-05-10 |
Novozymes A/S |
Microtiter plate (mtp) based high throughput screening (hts) assays
|
KR20020065517A
(ko)
*
|
1999-11-12 |
2002-08-13 |
맥시겐 홀딩스 리미티드 |
인터페론 감마 접합체
|
IL150109A0
(en)
|
1999-12-09 |
2002-12-01 |
Chiron Corp |
Method for administering a cytokine to the central nervous system and the lymphatic system
|
FR2802645B1
(fr)
|
1999-12-16 |
2002-03-08 |
Meillat Roland |
Methode d'evaluation de la performance d'un ensemble d'agents biologiques dans des cellules cibles vivantes et ses applications
|
US6555660B2
(en)
*
|
2000-01-10 |
2003-04-29 |
Maxygen Holdings Ltd. |
G-CSF conjugates
|
US6646110B2
(en)
*
|
2000-01-10 |
2003-11-11 |
Maxygen Holdings Ltd. |
G-CSF polypeptides and conjugates
|
AU2001238397A1
(en)
*
|
2000-02-17 |
2001-08-27 |
California Institute Of Technology |
Computationally targeted evolutionary design
|
AU780270B2
(en)
*
|
2000-02-23 |
2005-03-10 |
Association Francaise Contre Les Myopathies |
Treatment of immune diseases
|
FR2808804B1
(fr)
|
2000-05-09 |
2002-08-02 |
Nautilus Biotech |
Procede de determination du titre d'agents biologiques en temps reel dans des cellules cibles vivantes et ses applications
|
IL152706A0
(en)
*
|
2000-05-12 |
2003-06-24 |
Univ Wales Medicine |
Method for detecting growth hormone variations in humans, the variations and their uses
|
ES2290142T3
(es)
*
|
2000-05-16 |
2008-02-16 |
Bolder Biotechnology, Inc. |
Metodos para replegamiento de proteinas que contiene residuos de cisteina libre.
|
US7154958B2
(en)
*
|
2000-07-05 |
2006-12-26 |
Texas Instruments Incorporated |
Code division multiple access wireless system with time reversed space time block transmitter diversity
|
ATE479761T1
(de)
|
2000-07-31 |
2010-09-15 |
Biolex Therapeutics Inc |
Expression biologisch aktiver polypeptide in wasserlinse
|
US6846844B2
(en)
|
2000-08-18 |
2005-01-25 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US6946125B2
(en)
|
2000-08-23 |
2005-09-20 |
The New York Hospital Medical Center Of Queens |
Methods of treating West Nile virus infection
|
FR2813314B1
(fr)
|
2000-08-25 |
2004-05-07 |
Biomethodes |
Procede de mutagenese dirigee massive
|
US6946548B2
(en)
*
|
2000-09-08 |
2005-09-20 |
Massachusetts Institute Of Technology |
G-CSF analog compositions and methods
|
US20020169290A1
(en)
*
|
2000-11-02 |
2002-11-14 |
Claus Bornaes |
New multimeric interferon beta polypeptides
|
US20030072737A1
(en)
*
|
2000-12-29 |
2003-04-17 |
Michael Brines |
Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
|
US20060183197A1
(en)
*
|
2001-01-11 |
2006-08-17 |
Andersen Kim V |
Variant growth hormone molecules conjugated with macromolecules compounds
|
EP1392731B1
(de)
*
|
2001-02-06 |
2008-07-02 |
Merk Patent Gmbh |
Modifizierter granulozyten stimulierender factor (g-csf) mit verringerter immunogenität
|
BR0207015A
(pt)
*
|
2001-02-06 |
2004-07-06 |
Merck Patent Ges Mit Beschroen |
Eritropoientina modificada (epo) com imunogenicidade reduzida
|
JP2004532620A
(ja)
*
|
2001-02-19 |
2004-10-28 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング |
免疫原性の低減された人工タンパク質
|
JP2004535777A
(ja)
*
|
2001-03-08 |
2004-12-02 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング |
低減された免疫原性を有する修飾された顆粒球マクロファージコロニー刺激因子(gm−csf)
|
BR0208041A
(pt)
|
2001-03-15 |
2004-02-25 |
Merck Patent Gmbh |
Interferon beta modificado com imunogenicidade reduzida
|
WO2002079415A2
(en)
*
|
2001-03-30 |
2002-10-10 |
Lexigen Pharmaceuticals Corp. |
Reducing the immunogenicity of fusion proteins
|
FR2823220B1
(fr)
*
|
2001-04-04 |
2003-12-12 |
Genodyssee |
Nouveaux polynucleotides et polypeptides de l'erythropoietine (epo)
|
WO2002092619A2
(en)
*
|
2001-05-14 |
2002-11-21 |
The Gouvernment Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Modified growth hormone
|
US6833351B2
(en)
*
|
2001-05-21 |
2004-12-21 |
Douglas T. Dieterich |
Method of treating anemia caused by ribavirin treatment of hepatitis C using erythropoietin alpha
|
US6828305B2
(en)
*
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US20030129203A1
(en)
|
2001-08-27 |
2003-07-10 |
Nautilus Biotech S.A. |
Mutant recombinant adeno-associated viruses
|
US7647184B2
(en)
|
2001-08-27 |
2010-01-12 |
Hanall Pharmaceuticals, Co. Ltd |
High throughput directed evolution by rational mutagenesis
|
CA2459138A1
(en)
*
|
2001-09-04 |
2003-03-13 |
Merck Patent Gesellschaft Mit Beschraenkter Haftung |
Modified human growth hormone
|
US6688666B2
(en)
*
|
2001-09-13 |
2004-02-10 |
Colin G. Neale |
Second row fold and pivot seat assembly
|
US6930086B2
(en)
*
|
2001-09-25 |
2005-08-16 |
Hoffmann-La Roche Inc. |
Diglycosylated erythropoietin
|
ES2556338T3
(es)
*
|
2001-10-10 |
2016-01-15 |
Novo Nordisk A/S |
Remodelación y glicoconjugación de péptidos
|
US6786634B2
(en)
*
|
2001-10-10 |
2004-09-07 |
Noritake Co., Limited |
Temperature measuring method and apparatus
|
US7297511B2
(en)
|
2001-10-10 |
2007-11-20 |
Neose Technologies, Inc. |
Interferon alpha: remodeling and glycoconjugation of interferon alpha
|
EP1507540A4
(de)
*
|
2001-10-10 |
2006-12-06 |
Centocor Inc |
Nukleinsäureimpfstoffe unter verwendung von tumorantigen-kodierenden nukleinsäuren mit einer cytokinadjuvans-kodierenden nukleinsäure
|
MXPA04004291A
(es)
*
|
2001-11-09 |
2004-08-11 |
Upjohn Co |
Polimorfismos de un unico nucleotido en la gh-1.
|
GB0127213D0
(en)
*
|
2001-11-12 |
2002-01-02 |
Univ Wales Medicine |
Method of detecting growth hormone variations in humans the variations and their uses
|
GB2384001B
(en)
*
|
2001-12-14 |
2004-02-04 |
Asterion Ltd |
Chimeric growth hormone-growth hormone receptor proteins
|
US20030224404A1
(en)
|
2002-02-25 |
2003-12-04 |
Manuel Vega |
High throughput directed evolution of nucleic acids by rational mutagenesis
|
BR0312395A
(pt)
|
2002-07-01 |
2007-06-19 |
Kenneth S Warren Inst Inc |
citocina protetora de tecido recombinante de muteìna, célula de mamìfero responsiva à citocina protetora de tecido recombinante, molécula de ácido nucleico isolada, vetor, vetor de expressão, célula geneticamente engenheirada, célula, composição farmacêutica, método para proteger, manter ou realçar a viabilidade de uma célula, tecido ou órgão isolados de um corpo de mamìfero, uso de uma citocina protetora de tecido recombinante, método para facilitar a transcitose de uma molécula através de uma barreira de célula endotelial em um mamìfero, e, composição para transportar uma molécula por intermédio da transcitose através de uma barreira de célula endotelial
|
US6809191B2
(en)
*
|
2002-07-03 |
2004-10-26 |
Vaxim, Inc. |
GM-CSF nucleic acid sequences
|
KR20060003853A
(ko)
*
|
2002-08-09 |
2006-01-11 |
메르크 파텐트 게엠베하 |
에리트로포이에틴 내의 t-세포 에피토프
|
ATE386054T1
(de)
|
2002-08-31 |
2008-03-15 |
Cj Corp |
Glycosylierte humane interferon alpha isoform
|
US20050176627A1
(en)
*
|
2002-09-09 |
2005-08-11 |
Anthony Cerami |
Long acting erythropoietins that maintain tissue protective activity of endogenous erythropoietin
|
AU2003267700A1
(en)
|
2002-09-09 |
2004-03-29 |
Nautilus Biotech |
Rational directed protein evolution using two-dimensional rational mutagenesis scanning
|
ES2343518T3
(es)
*
|
2002-09-09 |
2010-08-03 |
Hanall Biopharma Co., Ltd. |
Polipeptidos interferon alfa modificados resistentes a proteasas.
|
US20050202438A1
(en)
|
2002-09-09 |
2005-09-15 |
Rene Gantier |
Rational directed protein evolution using two-dimensional rational mutagenesis scanning
|
US20060020396A1
(en)
*
|
2002-09-09 |
2006-01-26 |
Rene Gantier |
Rational directed protein evolution using two-dimensional rational mutagenesis scanning
|
US20050054053A1
(en)
*
|
2002-10-01 |
2005-03-10 |
Xencor, Inc. |
Interferon variants with improved properties
|
US20040137581A1
(en)
*
|
2002-10-01 |
2004-07-15 |
Xencor |
Interferon variants with improved properties
|
US7189740B2
(en)
*
|
2002-10-15 |
2007-03-13 |
Celgene Corporation |
Methods of using 3-(4-amino-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myelodysplastic syndromes
|
US20040091961A1
(en)
*
|
2002-11-08 |
2004-05-13 |
Evans Glen A. |
Enhanced variants of erythropoietin and methods of use
|
BR0316324A
(pt)
|
2002-11-18 |
2005-09-27 |
Maxygen Inc |
Polipeptìdeos e conjugados de interferon-alfa
|
PA8588901A1
(es)
*
|
2002-11-20 |
2005-02-04 |
Pharmacia Corp |
Conjugados de hormona de crecimiento humana pegilados n-terminales y proceso para su preparacion
|
US20040142870A1
(en)
*
|
2002-11-20 |
2004-07-22 |
Finn Rory F. |
N-terminally monopegylated human growth hormone conjugates, process for their preparation, and methods of use thereof
|
KR100541850B1
(ko)
|
2003-03-31 |
2006-01-11 |
삼성정밀화학 주식회사 |
인간 인터페론-베타 변이체 및 그의 제조방법
|
EP1636256A2
(de)
|
2003-06-10 |
2006-03-22 |
Xencor, Inc. |
Interferonvarianten mit verbesserten eigenschaften
|
KR100632985B1
(ko)
*
|
2003-07-26 |
2006-10-11 |
메덱스젠 주식회사 |
생리활성 조절 단백질의 효능 향상 방법 및 그 예시변이체들
|
CN101072789B
(zh)
*
|
2004-01-08 |
2013-05-15 |
生物种属学股份公司 |
肽的o-连接的糖基化
|
WO2005074524A2
(en)
*
|
2004-02-02 |
2005-08-18 |
Ambrx, Inc. |
Modified human interferon polypeptides and their uses
|
WO2005103076A2
(en)
|
2004-04-23 |
2005-11-03 |
Cambridge Antibody Technology Limited |
Erythropoietin protein variants
|
US20070265187A1
(en)
*
|
2004-04-29 |
2007-11-15 |
Slobodan Vukicevic |
Oral Formulations Comprising Bone Morphogenetic Proteins For Treating Metabolic Bone Diseases
|
AU2005273968A1
(en)
|
2004-08-09 |
2006-02-23 |
Alios Biopharma Inc. |
Synthetic hyperglycosylated, protease-resistant polypeptide variants, oral formulations and methods of using the same
|
WO2006029094A2
(en)
|
2004-09-02 |
2006-03-16 |
Xencor, Inc. |
Erythropoietin derivatives with altered immunogenicity
|
AU2005279308B2
(en)
|
2004-09-03 |
2012-05-03 |
Creabilis Therapeutics S.R.L. |
Protease resistant human and non-human HMGB1 Box-A mutants and their therapeutic/diagnostic use
|
US7998930B2
(en)
*
|
2004-11-04 |
2011-08-16 |
Hanall Biopharma Co., Ltd. |
Modified growth hormones
|
GB0500099D0
(en)
|
2005-01-05 |
2005-02-09 |
Cambridge Antibody Tech |
Methods and means relating to protein variants
|
WO2006120580A2
(en)
|
2005-05-04 |
2006-11-16 |
Nautilus Biotech |
Modified interferon-gamma polypeptides and methods for using modified interferon-gamma polypeptides
|
WO2007110230A2
(en)
|
2006-03-27 |
2007-10-04 |
Institut Pasteur |
Secreted proteins as early markers and drug targets for autoimmunity, tumorigenesis and infections
|
WO2007110231A2
(en)
*
|
2006-03-28 |
2007-10-04 |
Nautilus Biotech, S.A. |
MODIFIED INTERFERON-β (IFN-β) POLYPEPTIDES
|
EP2423307A1
(de)
*
|
2006-06-19 |
2012-02-29 |
Catalyst Biosciences, Inc. |
Modifizierte Gerinnungsfaktor-IV-Polypeptide und deren Verwendung bei der Behandlung
|
JP2010510794A
(ja)
*
|
2006-11-28 |
2010-04-08 |
ハナル ファーマシューティカル カンパニー リミテッド |
修飾型エリスロポエチンポリペプチド及びこの治療用用途
|
US20080260820A1
(en)
*
|
2007-04-19 |
2008-10-23 |
Gilles Borrelly |
Oral dosage formulations of protease-resistant polypeptides
|
KR101275950B1
(ko)
|
2008-05-29 |
2013-06-25 |
한올바이오파마주식회사 |
증가된 단백질분해효소 저항성을 나타내는 변형된 에리스로포이에틴(epo) 폴리펩티드 및 이의 약제학적 조성물
|